Journal
CELL RESEARCH
Volume 24, Issue 2, Pages 143-160Publisher
SPRINGERNATURE
DOI: 10.1038/cr.2013.151
Keywords
post-translational modifications; pluripotency-associated signaling; hESCs; hiPSCs
Categories
Funding
- Marie Mayer Foundation
- CIRM [TR1-01250, RT1-01108, CL1-00502]
- NIH [R33 MH087925]
- Esther O'Keeffe Foundation
Ask authors/readers for more resources
Post-translational modifications (PTMs) are known to be essential mechanisms used by eukaryotic cells to diversify their protein functions and dynamically coordinate their signaling networks. Defects in PTMs have been linked to numerous developmental disorders and human diseases, highlighting the importance of PTMs in maintaining normal cellular states. Human pluripotent stem cells (hPSCs), including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), are capable of self-renewal and differentiation into a variety of functional somatic cells; these cells hold a great promise for the advancement of biomedical research and clinical therapy. The mechanisms underlying cellular pluripotency in human cells have been extensively explored in the past decade. In addition to the vast amount of knowledge obtained from the genetic and transcriptional research in hPSCs, there is a rapidly growing interest in the stem cell biology field to examine pluripotency at the protein and PTM level. This review addresses recent progress toward understanding the role of PTMs (glycosylation, phosphorylation, acetylation and methylation) in the regulation of cellular pluripotency.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available